1. PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG HOSPITALIZED ELDERLY PATIENTS AND ASSOCIATED FACTORS
Main Article Content
Abstract
Background: Multimorbidity and polypharmacy are common problems among the older population.
They increase the risk of potentially inappropriate medication (PIMs) use and are related to adverse
events, falls, re-hospitalization and mortality.
Objectives: The study aimed to determine the prevalence and associated factors of PIMs in
hospitalized geriatric patients based on the 2019 Beers criteria.
Methods: A cross-sectional descriptive study was collected from the medical records of patients 65
years of age or older who were treated at the Cardiovascular Center, Thong Nhat Hospital, HCM
City, from December 2020 to June 2021. The PIMs were classified according to the 2019 Beers
criteria (AGS) version. We also collected the medication information (quantity, dosage, regime),
chronic diseases, Charlson comorbidities index, frailty, history of falls, and re-hospitalization in the
last year.
Results: A total of 215 eligible patients with 619 prescriptions were included. The mean age was 76.2
± 7.9 years. The frailty rate (CFS ≥ 5) was 54.9%. The ACCI scores were from 2 to 9. There were
88.4% of the patients took 5 or more medications simultaneously. The prevalence of PIMs use based
on the 2019 Beers criteria was 31.2%. The criteria on drugs to avoid, on drug–disease interactions
and drug–drug interactions were 87.6%, 10.4%, and 2%, respectively. The common PIMs were
long-acting benzodiazepines (27.2%). Logistic regression demonstrated that frailty, polypharmacy,
multiple comorbidities, and history of falls were positively associated with PIM use in older adults,
p < 0.05.
Conclusions: The prevalence of PIMs use was 31.2%. Factors that increase the risk of PIMs were
frailty, polypharmacy, history of falls, and rehospitalization.
Article Details
Keywords
Potentially inappropriate medication, 2019 beers criteria, elderly patients.
References
II tại Hà Nội 2021, link https://benhvienlaokhoa.
vn/hoi-nghi-lao-khoa-quoc-gia-lan-thu-ii
[2] Harrison SL, Kouladjian OL, Milte R et al.,
Costs of potentially inappropriate medication use
in residential aged care facilities. BMC Geriatr.
2018;18(1):9.
[3] American Geriatrics Society, 2019 updated
AGS Beers criteria for potentially inappropriate
medication use in older adults. J Am Geriatr Soc.
2019;67(4):674–694.
[4] Masumoto S, Sato M, Maeno T et al., Potentially
inappropriate medications with polypharmacy
increase the risk of falls in older Japanese
patients: 1-Year Prospective Cohort Study.
Geriatr Gerontol Int. 2018;18(7):1064–1070.
[5] Bonfiglio V, Umegaki H, Kuzuya M, Potentially
inappropriate medications and polypharmacy:7
a study of older people with mild cognitive
impairment and mild dementia. J Alzheimers Dis.
2019;71 (3):889–897.
[6] Wang P, Wang Q, Li F et al., Relationship between
potentially inappropriate medications and the risk
of hospital readmission and death in hospitalized
older patients. Clin Interv Aging. 2019;14:1871–
1878.
[7] Lê Thanh Hương, Đánh giá việc sử dụng thuốc
cho bệnh nhân cao tuổi điều trị nội trú theo tiêu
chuẩn Beers 2019, Tạp chí Y học TPHCM. 2019,
Tập 24 (2):122 - 130.
[8] Rockwood K, Song X, MacKnight C et al., A
global clinical measure of fitness and frailty in
elderly people. CMAJ. 2005;173:489-495.
[9] Katz S, Downs TD, Cash HR HRHR et al.,
Progress in development of the index of ADL.
Gerontologist. 1970;10 (1):20-30
[10] Charlson ME, Pompei P, Ales KL et al., A new
method of classifying prognostic comorbidity in
longitudinal studies: development and validation.
J Chronic Dis. 1987;40 (5):373-383
[11] Zhao M, Song JX, Zheng FF et al., Potentially
Inappropriate Medication and Associated Factors
Among Older Patients with Chronic Coronary
Syndrome at Hospital Discharge in Beijing.
Clinical Interventions in Aging. 2021;16 1047–
1056
[12] Jungo KT, Streit S, Lauffenburger JC, Utilization
and Spending on Potentially Inappropriate
Medications by US Older Adults with Multiple
Chronic Conditions using Multiple Medications.
Archives of Gerontology and Geriatrics.
2021(93); 104326
[13] Nguyễn Văn Cường, Khảo sát tình hình sử dụng
thuốc trên người bệnh cao tuổi nội trú theo tiêu
chuẩn Beers 2019. Tạp Chí Y Học VN. 2020, tập
496 (số đặc biệt): 182-8.
[14] Huang Y, Zhang L, Huang X et al., Potentially
inappropriate medications in Chinese
community-dwelling older adults. International
Journal of Clinical Pharmacy. 2020;(42)598–603
[15] Stafford G, Villén N, Roso-Llorach A et al.,
Combined Multimorbidity and Polypharmacy
Patterns in the Elderly: A Cross-Sectional Study
in Primary Health Care. Int. J. Environ. Res.
Public Health. 2021;18, 1-22
[16] Hudhra K, García-Caballos M, CasadoFernandez E et al.,
Polypharmacy and potentially
inappropriate prescriptions identified by Beers
and STOPP criteria in comorbid older patients
at hospital discharge. J Eval Clin Pract. 2016
;22(2):189–193. doi:10.1111/jep.12452
[17] Society of Critical Care Medicine, Guidelines
for the prevention and management of pain,
agitation/sedation, delirium, immobility, and
sleep disruption in adult patients in the ICU. Crit
Care Med. 2018;46 (9), pp. e825-e873.
[18] de Arau´jo NC, Silveira EA, Mota BG et al.,
Potentially inappropriate medications for the
elderly: Incidence and impact on mortality
in a cohort ten-year follow-up. PLoS ONE
2020;15(10): e0240104.
[19] Tian F, Liao S, Chen Z et al., The prevalence
and risk factors of potentially inappropriate
medication use in older Chinese inpatients with
multimorbidity and polypharmacy: a crosssectional study.
Ann Transl Med 2021;9(18):1483